NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED

Status Recruiting

Clinical Trial Summary

The purpose of this study is to evaluate the effect of NAC or sodium bicarbonate in preventing the aggravation of renal function in chronic renal failure when enhanced computed tomography scan is checked in emergency room.

Clinical Trial Description

CIN is frequent in CRF patients. However most studies about CIN has been focusing on elective PCI patients. There is no study that the NAC nor sodium bicarbonate would help in preventing CIN in CRF patients who need enhanced CT scan in ED.

Our intention was to investigate the effect of NAC or sodium bicarbonate in preventing the aggravation of renal function in chronic renal failure when enhanced computed tomography scan is checked in emergency room. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00501475
Study type	Interventional
Source	Seoul National University Hospital
Contact	Kyuseok Kim, M.D
Phone	82-31-787-3049
Email	dremkks@snubh.org
Status	Recruiting
Phase	Phase 4
Start date	March 2007
Completion date	October 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02565459` - MSC and Kidney Transplant Tolerance (Phase A)	Phase 1
Recruiting	`NCT02356419` - rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics	Phase 1
Recruiting	`NCT01876017` - Safety and Efficacy of BMMNC in Patients With Chronic Renal Failure	Phase 1/Phase 2
Withdrawn	`NCT03019159` - Assessment of a Follow-up With Tele-consulting for Patients With Renal Failure Under Peritoneal Dialysis	N/A
Completed	`NCT02047006` - Dose-finding of Rivaroxaban in Hemodialysis	Phase 4
Completed	`NCT01617824` - Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes	Phase 4
Completed	`NCT00828776` - Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure	Phase 2/Phase 3
Completed	`NCT00597753` - Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis	Phase 3
Terminated	`NCT00372489` - Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD	Phase 2
Completed	`NCT00379899` - ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis	Phase 4
Completed	`NCT00228436` - Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients	Phase 2
Completed	`NCT03772171` - Estimate for Dietary Intakes and Hemodialysis Patients
Recruiting	`NCT02586402` - Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis	Phase 2
Completed	`NCT01879618` - Use Of Fragmin In Hemodialysis	Phase 3
Not yet recruiting	`NCT01346215` - Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure	Phase 3
Completed	`NCT01220843` - FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease	Phase 3
Completed	`NCT01111630` - Study of Erythropoietin (EPO) Administration Schedule	Phase 4
Completed	`NCT00742716` - Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease	Phase 2
Completed	`NCT00598273` - Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis	Phase 3
Completed	`NCT00597584` - Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis	Phase 3